Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Exelixis (EXEL) reported $610.81 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 10%. EPS of $0.87 for the same period compares to $0.62 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $612.57 million, representing a surprise of -0.29%. The company delivered an EPS surprise of +15.55%, with the consensus EPS estimate being $0.75.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Exelixis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Collaboration revenues: $55.84 million compared to the $49.26 million average estimate based on seven analysts. The reported number represents a change of -17769.3% year over year.Revenues- Net product revenues: $554.98 million versus the seven-analyst average estimate of $563.31 million. The reported number represents a year-over-year change of +8.1%.Revenues- Net product revenues- COMETRIQ: $2.2 million versus the six-analyst average estimate of $2.51 million. The reported number represents a year-over-year change of -8.8%.Revenues- Net product revenues- CABOMETYX: $552.8 million versus $558.02 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +8.2% change.View all Key Company Metrics for Exelixis here>>>Shares of Exelixis have returned +0.4% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks